John Reites and Julio Martinez-Clark discuss the opportunities available to accelerate clinical research timelines in Latin America. They also highlight the advantages of conducting trials in Latin America, where faster approvals are possible, new country options are now available and cost-effective processes are transforming the clinical research landscape. The conversation explores strategic insights into leveraging this regions for your clinical trials. Click here to message/text me your i...
All content for Inclusion Criteria: a Clinical Research podcast is the property of John Reites and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
John Reites and Julio Martinez-Clark discuss the opportunities available to accelerate clinical research timelines in Latin America. They also highlight the advantages of conducting trials in Latin America, where faster approvals are possible, new country options are now available and cost-effective processes are transforming the clinical research landscape. The conversation explores strategic insights into leveraging this regions for your clinical trials. Click here to message/text me your i...
FDA's ELSA AI: What It Means (so far) for Clinical Research
Inclusion Criteria: a Clinical Research podcast
5 minutes
5 months ago
FDA's ELSA AI: What It Means (so far) for Clinical Research
John Reites reviews what we know (so far) about FDA's AI tool named ELSA. He provides his insights on what ELSA is, why it matters to Clinical Research, how the industry currently views it and what he personally thinks about ELSA. Click here to message/text me your insights and ideas for future episodes Thank you for joining Inclusion Criteria: a Clinical Research podcast hosted by me, John Reites. This is an inclusive, non-corporate podcast focused on the people and topics that matter to dev...
Inclusion Criteria: a Clinical Research podcast
John Reites and Julio Martinez-Clark discuss the opportunities available to accelerate clinical research timelines in Latin America. They also highlight the advantages of conducting trials in Latin America, where faster approvals are possible, new country options are now available and cost-effective processes are transforming the clinical research landscape. The conversation explores strategic insights into leveraging this regions for your clinical trials. Click here to message/text me your i...
